Orally Administered Antineoplastic Medication Cost-Sharing ____________________________________________________

STATE OF MICHIGAN DEPARTMENT OF INSURANCE AND FINANCIAL SERVICES Bulletin 2026-02-INS In the matter of: Orally Administered Antineoplastic Medication Cost-Sharing ____________________________________________________/ Issued and entered this 13th day of January 2026 by Anita G. Fox Director The Department of Insurance and Financial Services (the Department) issues this bulletin to inform health insurers of the adjustment to the co-pay and coinsurance cap for orally administered antineoplastic medication in accordance with MCL 500.3406ff(1)(b). Under MCL 500.3406ff(1)(b), the Department must adjust the co-pay and coinsurance cap on an annual basis by the amount determined by the state treasurer to reflect the cumulative annual change in the prescription drug index of the medical care component of the United States Consumer Price Index. This bulletin informs interested parties that the state treasurer has determined the adjustment for calendar year 2026 to be $254.75. Any questions regarding this bulletin should be directed to: Department of Insurance and Financial Services Office of General Counsel 530 West Allegan Street, 7th Floor Lansing, Michigan 48933 Toll Free: (877) 999-6442 /s/ _________________________________________ Anita G. Fox Director